Preserved solid lipid nanoparticles (SLN) at low concentrations do cause neither direct nor indirect cytotoxic effects in peritoneal macrophages

International Journal of Pharmaceutics

Volumn 196, Issue 2, 2000, Pages 235-239

  Schöler, Nadja ^a   Zimmermann, Eike ^a   Katzfey, Ulrike ^a   Hahn, Helmut ^a   Müller, Rainer H ^a   Liesenfeld, Oliver ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Cytokines; Cytotoxicity; Peritoneal macrophages; Solid lipid nanoparticles (SLN)

Indexed keywords

CYTOKINE; GLYCEROL DERIVATIVE; INTERLEUKIN 12; INTERLEUKIN 6; LIPID; NANOPARTICLE; PALMITIC ACID DERIVATIVE; POLOXAMER; THIOMERSAL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; FEMALE; IMMUNOMODULATION; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0141719280     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00430-5     Document Type: Article

References (15)

1. Ascenzi, J.M. (Ed.), 1996. Handbook of disinfectants and antiseptics, Marcel Dekker, New York.
2. Baumann H., Gauldie J. The acute phase response. Immunol. Today. 15:1994;74-88.
3. Fassihi R.A. Preservation of medicines against microbial contamination. Block S.S. Disinfection, Sterilization, and Preservation. fourth ed:1991;871-886 Lea and Febiger, Philadelphia.
4. + T cells and accompanied by overproduction of IL-12, IFN-γ, and TNF-α J. Immunol. 157:1996;798-805.
5. Howard M.T., Muchamuel T., Andrade S., Menon S. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1993;1205.
6. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Methods. 65:1983;55-63.
7. Mueller, R.H., Lucks, J.S., 1991. German Patent Applications, P 4131562.6.
8. Mueller R.H., Mehnert W., Lucks J.S., Schwarz C., zur Muehlen A., Weyhers H., Freitas C., Ruehl D. Solid lipid nanoparticles (SLN) - an alternative colloidal carrier system for controlled drug delivery. Eur. J. Pharm. Biopharm. 41:1995;62-69.
9. Schöler, N., Zimmermann, E., Katzfey, U., Hahn. H., Mueller, R.H., Liesenfeld, O., 1999. Effect of solid lipid nanoparticles on cytokine production by, and viability of murine peritoneal macrophages. J. Microencapsul. (in press).
10. Schwarz C., Mehnert W., Lucks J.S., Mueller R.H. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterisation, and sterilisation. J. Control. Release. 30:1993;83-96.
11. Takahashi N. Cytotoxicity of mercurial preservatives in cell culture. Ophthalmic Res. 14:1982;63-69.
12. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood. 84:1994;4008-4027.
13. US Pharmacopeia XXII, 1990. US Pharmacopeial Convention, Rockville, MD.
14. Van Furth R., Cohn Z.A., Hirsch J.G., Humphrey J.H., Spector W.G., Langevoort H.L. The mononuclear phagocyte system: a new classification of macrophages and their precursor cells. Bull. WHO. 46:1997;845.
15. Withrow T.J., Brown N.T., Hitchins V.M., Strickland A.G. Cytotoxicity and mutagenicity of ophthalmic solution preservatives and UVA radiation in L5178Y cells. Photochem. Photobiol. 50:1989;385-385.